• 已选条件：
  • × AlphaMed Press Incorporated
  • × BCR-ABL
 全选  【符合条件的数据共：1条】

1 U.S. Food and Drug Administration Benefit-Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission [期刊论文]

来源：The oncologist , 2019

作者:E. Dianne Pulte;Tanya Wroblewski;Erik Bloomquist;等

关键词:Chronic myeloid leukemia;Tyrosine kinase inhibitors;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]